Cargando…
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide
Temozolomide (TMZ) is an oral alkylating agent that is considered the standard therapy in primary intracranial malignancies. The medication is well tolerated with a most common side effect of bone marrow suppression that is encountered in a small proportion of patients, often reversible with medicat...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670352/ https://www.ncbi.nlm.nih.gov/pubmed/33250738 http://dx.doi.org/10.1159/000509744 |